The median κ‐FLC index was lower in the GFAP‐astrocytopathy group than in the MS group (26.1 [11.4; 78.4] vs. 65.5 [35.7; 118.3], respectively; p = 0.062). This evidence concerns the gene GFAP and myeloid sarcoma.